References
- Müller A., Cadenas E., Graf P., Sies H. A novel biologically active selenoorganic com-pound-I: Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen). Biochemical Pharmacology 1984; 33: 3235–3239
- Wendel A., Fausel M., Safayhi H., Tiegs G., Otter R. A novel biologically active selenoogranic compound II: Activity of PZ 51 in relation to glutathione peroxidase. Biochemical Pharmacology 1984; 33: 3241–3245
- Hayashi M., Slater T. F. Inhibitory effects of ebselen on lipid peroxidation in rat liver microsomes. Free Radical Research Communications 1986; 2: 179–185
- Schöneich C., Narayanaswami V., Asmus K. D., Sies H. Reactivity of ebselen and related selenoorganic compounds with 1,2-dichloroethane radical cations and halogenated peroxyl radicals. 1990, (Archives of Biochemistry and Biophysics, submitted)
- Packer J. E., Slater T. F., Willson R. L. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature (London) 1979; 278: 737–738
- Müller A., Gabriel H., Sies H., Terlinden R., Fischer H., Romer A. A novel biologically active selenoorganic compound-VII: Biotransformation of ebselen in perfused rat liver. Biochemical Pharmacology. 1988; 37: 1103–1109
- Wendel A., Otter R., Tiegs G. Inhibition by ebselen of microsomal NADPH-cytochrome P450-reductase in vitro but not in vivo. Biochemical Pharmacology 1986; 35: 2995–2997
- Nagi M. N., Laguna J. C., Cook L., Cinti D. L. Disruption of rat hepatic microsomal electron transport chain by the selenium-containing anti-inflammatory agent ebselen. Archives of Biochemistry and Biophysics 1989; 269: 264–271
- Kuhn-Velten N., Sies H. Optical spectral studies of ebselen's interaction with cytochrome P-450 of rat liver microsomes. Biochemical Pharmacology 1989; 38: 619–625
- Cadenas E., Sies H. Low-level chemiluminescence as an indicator of singlet molecular oxygen in biological systems. Methods in Enzymology 1984; 105: 221–231
- Haenen G. R.M.M., Bast A. Protection against lipid peroxidation by a microsomal glutathione dependent labile factor. FEBS Letters 1983; 159: 24–28
- Murphy M. E., Kehrer J. P. Simultaneous measurement of tocopherols and tocopheryl quinones in tissue fractions using high-performance liquid chromatography with redox cycling electrochemical detection. Journal of Chromatography 1987; 421: 71–82
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin Phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Fischer H., Dereu N. Mechanism of the catalytic reduction of hydroperoxides by ebselen: A selenium-77 NMR study. Bulletin de Societe Chimie. Belgique 1987; 96: 757–768
- Müller A., Gabriel H., Sies H. A novel biologically active selenoorganic compound-IV: Protective glutathione-dependent effect of PZ 51 (ebselen) against ADP/Fe induced lipid peroxidation in isolated hepatocytes. Biochemical Pharmacology 1985; 34: 1185–1189
- Kamigata N., Takata M., Matsuyama H., Kobayashi M. Novel ring opening reaction of 2-aryl-1,2-benzisoselenazol-3(2H)-one with thiols. Heterocycles 1986; 24: 3027–3030
- Glass R., Farooqui F., Sabahi M., Ehler K. Formation of thiocarbonyl compounds in the reaction of ebselen oxide with thiols. Journal of Organic Chemistry 1989; 54: 1092–1097
- Lambert C., Cantineau R., Christiaens L., Biedermann J., Dereu N. Syntheses and spectral characterization of the metabolites of a new organo-selenium drug: ebselen. Bulletin de Societe Chimie. Belgique. 1987; 96: 383–389